Jonathan Abbas, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Consultancy
    Date added:
    09/12/2023
    Date updated:
    09/12/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Consultancy
    Date added:
    09/12/2023
    Date updated:
    09/12/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Incyte
    Topic:
    Consultancy
    Date added:
    09/12/2023
    Date updated:
    09/12/2023
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genmab
    Topic:
    Consultancy
    Date added:
    09/12/2023
    Date updated:
    09/12/2023
    Relationship end date:
    12/31/2023
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice